Headquarters
3002 48TH AVE STE 290, LONG ISLAND CITY, NY 11101-3432, US
LONG ISLAND CITY, NY, US
ENVISAGENICS INC
From the company
Envisagenics is a biotechnology company that uses its AI platform, SpliceCore®, to power the discovery and therapeutic targeting of RNA splicing. Combining expertise in RNA biology and AI, the company discovers novel, disease-specific drug targets in immuno-oncology and RNA-targeted treatments for neurodegenerative diseases. Founded in 2014, it is based in Long Island City, New York.
Products & services offered
Capabilities 4
Classifications
- Ownership classifications (2)
- Hispanic American Owned, Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.